Merv Fingas, head of the Emergencies Science Division at Canada's Environmental Technology Center in Ottawa, Ontario and Editor of Journal of Hazardous Materials remarks, "Scopus is a great asset to my journal work. I use it all the time to find reviewers – in fact, I have stopped using my own database of reviewers as I find Scopus much more effective."
Launched in 2003, EES is an online submission and peer-review system which enhances the journal publication process by providing a seamless end-to-end online workflow. Herman van Campenhout, CEO Science & Technology, Elsevier, adds "Since EES recently welcomed its thousandth journal to the system; we are pleased to report that the time needed for the complete editorial process – from submission to acceptance – has been reduced by almost 9 weeks. Adding Scopus underscores our ongoing commitment to our reviewers and editors with best-in-class publishing services."
"EES and Scopus are a natural fit. Making Scopus accessible to our reviewers and editors is a significant step in Elsevier's commitment to support the research community in the fundamentally important task of peer review" says Jaco Zijlstra, Director of Scopus.
About Scopus
Covering the world's research literature, Scopus is the largest and easiest to use navigation tool ever built. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 14,000 titles from 4,000 different publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit www.info.scopus.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide.
Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Notes to Editors:
Please contact Elsevier's E-Submission Support department for detailed questions concerning the EES system.
E-submissionsupport@elsevier.com
Editors: editorsupport@elsevier.com
Reviewers: reviewersupport@elsevier.com
Authors: authorsupport@elsevier.com
US & Canada: +1 888 834 7287 (toll-free for US & Canadian customers)
Asia & Pacific: +81 3 5561 5032
Europe & ROW: +353 61 709 190